Howard I. Hoffen

Howard I. Hoffen has 124 filings from March 29, 2016 to October 6, 2026, of which 122 as a Director of EnerSys, 1 at Jasper Therapeutics, Inc. and 1 at Jones Energy, Inc.

A sale of EUR 488,025 at EnerSys, on February 26, 2025, is the only market trade; no purchase. The rest is almost entirely 121 grants, with 1 option exercise and 1 other line.

The yearly volume is 4 to 6 filings through 2021, then climbs to 16 in 2022, 32 in 2023, the peak, and 27 in 2024, before falling back to 11 in 2025 and 7 in 2026. Nine filings fall in the last twelve months, with no market trade. The median publication delay is 4 days, across 123 dated filings, and the 122 EnerSys filings are nearly all of them. A single trade by Howard I. Hoffen sits within 30 days of a trade by David M. Shaffer, in the same direction.